DRO Price sensitive 13 Oct 2025, 8:37 AM

DroneSentry Solution Recognised as NPSA Rated

Droneshield Ltd

DroneShield's DroneSentry Solution Recognised as NPSA Rated

Key points

  • DroneShield's DroneSentry solution has been recognised by the UK Government's National Protective Security Authority (NPSA)
  • NPSA provides UK Government agency standard evaluation for counter drone systems
  • DroneShield counterdrone solutions are available within the UK exclusively through BT

Full summary

DroneShield Limited (ASX:DRO) is pleased to announce that its DroneSentry multi-layered counterdrone solution has been successfully evaluated by the National Protective Security Authority (NPSA), an agency of the UK Government. The DroneSentry solution is now included within the NPSA's Catalogue of Security Equipment (CSE), providing confidence to prospective buyers of the solution following NPSA's rigorous testing. DroneShield's extensive range of counter drone solutions are available exclusively through BT within the UK. The DroneSentry solution is underpinned by an AI-enabled command-and-control engine, DroneSentry-C2, which formed part of the NPSA evaluation and recognition. The C2 engine, a SaaS product, enables integration of a wide range of sensors and effectors, to optimise for the end user requirements and budget. While the dollar amount of expected sales associated with the NPSA results cannot be quantified at this time, it is expected to be material as the demand for counterdrone solutions rises, and the Company will provide further guidance when available. The DroneSentry solution comprises of an upfront purchase of hardware, combined with one or multiple SaaS packages, and has been deployed to date in Europe, Asia Pacific, the US, South America and Australia.

Guidance

The dollar amount of expected sales associated with the NPSA results cannot be quantified at this time, but is expected to be material as the demand for counterdrone solutions rises.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in